These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 26707692)

  • 1. RE: Evaluation of the performance of the insulin-like growth factor-binding protein-1/alpha-fetoprotein test in diagnosing ruptured fetal membranes in pregnant women.
    Ruanphoo P; Phupong V
    J Perinatol; 2016 Jan; 36(1):77-8. PubMed ID: 26707692
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of the performance of the insulin-like growth factor-binding protein-1/alpha-fetoprotein test in diagnosing ruptured fetal membranes in pregnant women.
    Abdelazim IA
    J Perinatol; 2016 Jan; 36(1):77. PubMed ID: 26707691
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of the performance of the insulin-like growth factor-binding protein-1/alpha-fetoprotein test in diagnosing ruptured fetal membranes in pregnant women.
    Ruanphoo P; Phupong V
    J Perinatol; 2015 Aug; 35(8):558-60. PubMed ID: 25719545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the duo of insulin-like growth factor binding protein-1/alpha fetoprotein (Amnioquick duo+®) and traditional clinical assessment for diagnosing premature rupture of fetal membranes.
    Eleje GU; Ezugwu EC; Eke AC; Ikechebelu JI; Obiora CC; Ojiegbe NO; Ezebialu IU; Ezeama CO; Nwosu BO; Udigwe GO; Okafor CI; Ezugwu FO
    J Perinat Med; 2017 Jan; 45(1):105-112. PubMed ID: 27855117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosing rupture of membranes using combination monoclonal/polyclonal immunologic protein detection.
    Thomasino T; Levi C; Draper M; Neubert AG
    J Reprod Med; 2013; 58(5-6):187-94. PubMed ID: 23763001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Detection of premature rupture of fetal membranes by determining insulin-like-growth-factor-binding protein-1].
    Woltmann W; Hofstaetter C; Dudenhausen JW
    Z Geburtshilfe Neonatol; 1995; 199(6):243-4. PubMed ID: 8581849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of insulin like growth factor binding protein-1 in the diagnosis of ruptured fetal membranes.
    Jeurgens-Borst AJ; Bekkers RL; Sporken JM; van den Berg PP
    Eur J Obstet Gynecol Reprod Biol; 2002 Apr; 102(1):11-4. PubMed ID: 12039083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the use of IGFB-1 for diagnosing ROM of any clinical value.
    Ladfors L; Mattsson LA
    Acta Obstet Gynecol Scand; 1999 Jul; 78(6):557-8. PubMed ID: 10376870
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of latex agglutination test for alpha-fetoprotein in diagnosing rupture of fetal membranes.
    Watanabe T; Minakami H; Itoi H; Sato I; Sakata Y; Tamada T
    Gynecol Obstet Invest; 1995; 39(1):15-8. PubMed ID: 7534254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Insulin-like growth factor binding protein 1 (IGFBP-1) in vaginal secretion as a marker of premature rupture of amniotic membranes].
    Woytoń J; Kłósek A; Zimmer M; Fuchs T
    Ginekol Pol; 1999 Nov; 70(11):809-14. PubMed ID: 10736957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of cervicovaginal fluid in the diagnosis of premature rupture of membranes].
    Knapik D; Olejek A
    Ginekol Pol; 2011 Jan; 82(1):50-5. PubMed ID: 21473055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical application of immunomagnetic reduction for quantitative measurement of insulin-like growth factor binding protein-1 in the prediction of pregnant women with preterm premature rupture of membranes.
    Chen CY; Chang CC; Lin CW
    Clin Chim Acta; 2015 Jan; 438():337-41. PubMed ID: 25281931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor binding protein-1 (Actim PROM test) for detection of premature rupture of fetal membranes.
    Abdelazim IA
    J Obstet Gynaecol Res; 2014 Apr; 40(4):961-7. PubMed ID: 24612210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of three amniotic fluid markers in premature rupture of membranes: prolactin, beta subunit of human chorionic gonadotropin, and alpha-fetoprotein.
    Shahin M; Raslan H
    Gynecol Obstet Invest; 2007; 63(4):195-9. PubMed ID: 17159350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rapid colorimetric AFP monoclonal antibody test for the diagnosis of preterm rupture of the membranes.
    Rochelson BL; Rodke G; White R; Bracero L; Baker DA
    Obstet Gynecol; 1987 Feb; 69(2):163-6. PubMed ID: 2433650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor binding protein-1, a quick way to detect amniotic fluid.
    Darj E; Lyrenäs S
    Acta Obstet Gynecol Scand; 1998 Mar; 77(3):295-7. PubMed ID: 9539275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid assay--possible application in the diagnosis of premature rupture of the membranes.
    Rochelson BL; Richardson DA; Macri JN
    Obstet Gynecol; 1983 Oct; 62(4):414-8. PubMed ID: 6193467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of Insulin-like growth factor binding protein-1, placental alpha-microglobulin-1, phenol and pH for the diagnosis of preterm premature rupture of membranes between 20 and 36 weeks.
    Galletta MAK; Bittar RE; Rodrigues AS; Francisco RPV; Zugaib M
    J Obstet Gynaecol Res; 2019 Aug; 45(8):1448-1457. PubMed ID: 31099162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of preterm rupture of membranes: is testing for alpha-fetoprotein better than ferning or nitrazine?
    Garite TJ; Gocke SE
    Am J Perinatol; 1990 Jul; 7(3):276-8. PubMed ID: 1695510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy and response time of dual biomarker model of insulin-like growth factor binding protein-1/ alpha fetoprotein (Amnioquick duo+) in comparison to placental alpha-microglobulin-1 test in diagnosis of premature rupture of membranes.
    Eleje GU; Ezugwu EC; Eke AC; Ikechebelu JI; Ezeama CO; Ezebialu IU; Ojiegbe NO; Obiora CC; Okafor CI; Udigwe GO; Nwosu BO; Ezugwu FO
    J Obstet Gynaecol Res; 2017 May; 43(5):825-833. PubMed ID: 28422393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.